Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
83.94
+0.13 (0.16%)
Dec 5, 2025, 4:00 PM EST - Market closed
Haemonetics Stock Forecast
Stock Price Forecast
According to 9 professional analysts, the 12-month price target for Haemonetics stock ranges from a low of $62 to a high of $100. The average analyst price target of $79.67 forecasts a -5.09% decrease in the stock price over the next year.
Price Target: $79.67 (-5.09%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Haemonetics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 4 | 2 | 2 | 3 |
| Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Hold | 2 | 1 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 11 | 8 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $88 | Strong Buy | Reiterates | $88 | +4.84% | Nov 21, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $86 → $90 | Buy | Maintains | $86 → $90 | +7.22% | Nov 7, 2025 |
| Needham | Needham | Strong Buy Maintains $68 → $78 | Strong Buy | Maintains | $68 → $78 | -7.08% | Nov 7, 2025 |
| BTIG | BTIG | Strong Buy Maintains $85 → $88 | Strong Buy | Maintains | $85 → $88 | +4.84% | Nov 6, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $86 | Buy | Maintains | $86 | +2.45% | Oct 21, 2025 |
Financial Forecast
Revenue This Year
1.33B
from 1.36B
Decreased by -2.19%
Revenue Next Year
1.41B
from 1.33B
Increased by 6.01%
EPS This Year
4.96
from 3.31
Increased by 49.93%
EPS Next Year
5.55
from 4.96
Increased by 11.75%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.4B | 1.5B | |
| Avg | 1.3B | 1.4B | |
| Low | 1.3B | 1.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.1% | 11.9% | |
| Avg | -2.2% | 6.0% | |
| Low | -5.6% | 0.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.20 | 5.90 | |
| Avg | 4.96 | 5.55 | |
| Low | 4.75 | 5.27 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 57.0% | 18.9% | |
| Avg | 49.9% | 11.8% | |
| Low | 43.6% | 6.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.